Improving Deceased-Donor Kidney Transplant Outcomes Via a Single Intragraft Injection of C1 Esterase Inhibitor (IMPROVE TRIAL)
for Kidney Transplant
Sites in Los Angeles +3 more locations
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Sex: All·Age: 18 - 75
Code: NCT06919003·Phase 2·Recruiting·Listed Apr 2025